Endoscopy,Sedation. Failed moderate sedation during procedure
Conditions
Interventions
Intervention 1: Intervention group:The intervention group will receive Propofol 0.5 mg/kg and Ketamine 0.5 mg/kg, intravenous Lidocaine 2% 1.5 mg/kg made in Daroupakhsh company in Iran. Intervention 2
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Candidate patients under 18 to 65 years of age who are in groups 1 and 2 according to the American Society of Anesthesiology (ASA Class)
Exclusion criteria
Exclusion criteria: Patients with severe heart or lung disease are not included in this study Patients with Renal failure are not included in this study Patients with Liver failure are not included in this study Patients allergic to Propofol, Ketamine, or Lidocaine are not included in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total amount of Propofol consumed. Timepoint: From start to end of endoscopy. Method of measurement: Dose of drug.;Level of sedation. Timepoint: From start to end of endoscopy. Method of measurement: Ramsay Sedation Scale.;Amount of pain. Timepoint: From start to one hour after Endoscopy. Method of measurement: Visual Analogue Scale.;Amount of Nausea and Vomiting. Timepoint: From start to end of Endoscopy. Method of measurement: Visual Analogue Scale.;Time of recovery. Timepoint: From start to end of Endoscopy. Method of measurement: From end of endoscopy to full consciousness.;Hemodynamic instability. Timepoint: From start to end of Endoscopy. Method of measurement: Amount of Heart rate, mean arterial pressure and blood oxygen saturation changes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Keshavarzi
Ahvaz University of Medical Sciences
Outcome results
None listed